MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13.

Wang Y, Hu S, Zhang H, Zhang C, Lian Q, Jiao Y, Zhou Y

DOI: 10.1155/2022/4891889
Published: 2022
Container: Journal of healthcare engineering
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2022/4891889,
  title = {MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13.},
  author = {Wang Y and Hu S and Zhang H and Zhang C and Lian Q and Jiao Y and Zhou Y},
  year = {2022},
  journal = {Journal of healthcare engineering},
  doi = {10.1155/2022/4891889},
  url = {https://doi.org/10.1155/2022/4891889}
}

RIS

TY  - JOUR
TI  - MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13.
AU  - Wang Y
AU  - Hu S
AU  - Zhang H
AU  - Zhang C
AU  - Lian Q
AU  - Jiao Y
AU  - Zhou Y
PY  - 2022
JO  - Journal of healthcare engineering
DO  - 10.1155/2022/4891889
UR  - https://doi.org/10.1155/2022/4891889
ER  -

APA

Y, W., S, H., H, Z., C, Z., Q, L., Y, J., & Y, Z. (2022). MiRNA-186-5p Exerts an Anticancer Role in Breast Cancer by Downregulating CXCL13.. Journal of healthcare engineering. https://doi.org/10.1155/2022/4891889

Source records

pubmed · retrieved 2026-09-25T04:09:14.901Z